BEAM vs UPS · rev $63.5M vs P/E 15, rev $88.66B
Beam Therapeutics Inc (BEAM) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
BEAM currently screens at market cap $2.01B. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the BEAM and UPS stock pages for the full models.
Not investment advice.